Freudenberg Nicholas, Lee Kelley, Buse Kent, Collin Jeff, Crosbie Eric, Friel Sharon, Klein Daniel Eisenkraft, Lima Joana Madureira, Marten Robert, Mialon Melissa, Zenone Marco
Nicholas Freudenberg is with the Graduate School of Public Health and Health Policy, City University of New York, New York, NY. Kelley Lee is with the Faculty of Health Sciences, Simon Fraser University, Burnaby, Vancouver, BC, Canada. Kent Buse is with The George Institute for Global Health, School of Public Health, Imperial College London, UK. Jeff Collin is with the Global Health Policy Unit, School of Social and Political Science, University of Edinburgh, Scotland. Eric Crosbie is with the School of Community Health Sciences, University of Nevada‒Reno. Sharon Friel is with the Menzies Centre for Health Governance, School of Regulation and Global Governance, Australian National University, Canberra, Australia. Daniel Eisenkraft Klein is with the Dalla Lana School of Public Health, University of Toronto, Canada. Joana Madureira Lima is with the World Health Organization, Regional Office for Europe, Kyrgyzstan Country Office, Bishkek, Kyrgyzstan. Robert Marten is with the Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland. Melissa Mialon is with Trinity Business School, Trinity College, Dublin, Ireland. Marco Zenone is with the London School of Hygiene and Tropical Medicine, London, UK.
Am J Public Health. 2021 Dec;111(12):2202-2211. doi: 10.2105/AJPH.2021.306491.
In recent years, the concept of commercial determinants of health (CDoH) has attracted scholarly, public policy, and activist interest. To date, however, this new attention has failed to yield a clear and consistent definition, well-defined metrics for quantifying its impact, or coherent directions for research and intervention. By tracing the origins of this concept over 2 centuries of interactions between market forces and public health action and research, we propose an expanded framework and definition of CDoH. This conceptualization enables public health professionals and researchers to more fully realize the potential of the CDoH concept to yield insights that can be used to improve global and national health and reduce the stark health inequities within and between nations. It also widens the utility of CDoH from its main current use to study noncommunicable diseases to other health conditions such as infectious diseases, mental health conditions, injuries, and exposure to environmental threats. We suggest specific actions that public health professionals can take to transform the burgeoning interest in CDoH into meaningful improvements in health. (. 2021;111(12):2202-2211. https://doi.org/10.2105/AJPH.2021.306491).
近年来,健康的商业决定因素(CDoH)概念引起了学术界、公共政策领域以及社会活动家的关注。然而,迄今为止,这种新的关注尚未产生一个清晰一致的定义、用于量化其影响的明确指标,也没有连贯的研究和干预方向。通过追溯这一概念在市场力量与公共卫生行动及研究之间两个多世纪互动中的起源,我们提出了一个扩展的CDoH框架和定义。这种概念化使公共卫生专业人员和研究人员能够更充分地认识到CDoH概念的潜力,从而获得可用于改善全球和国家健康状况、减少国家内部和国家之间严重健康不平等现象的见解。它还将CDoH的效用从目前主要用于研究非传染性疾病扩展到其他健康状况,如传染病、心理健康状况、伤害以及接触环境威胁等。我们建议公共卫生专业人员采取具体行动,将对CDoH日益增长的兴趣转化为对健康的切实改善。(. 2021;111(12):2202 - 2211. https://doi.org/10.2105/AJPH.2021.306491)